Search

Rachel Samson (National Collection of Industrial Microorganisms, India) and colleagues wrote a new review on the status quo and emerging trends of phages in a One Health context.

iVoM is the online community of ISVM, and it's back for a third live webinar series! We just announced the first session: Ecological and functional roles of viruses, with speakers from Max Planck Institute, Weizmann Institute, UC Berkeley,

Viruses of Microbes (VoM) 2024 is happening in Cairns, Australia July 15-19 2024. This is the International Society for Viruses of Microbes (ISVM)'s flagship biennial conference, held outside of Europe next year for the very first time! Abs

Viruses of Microbes UK, a local subsidiary of VoM, will take place January 25-26, 2024 at Northumbria University, Newcastle upon Tyne, UK. This will be a two-day round table and phage genomics workshop, highlighting the latest research on p

Grace Beggs and colleagues at Princeton University are organizing a workshop called "Bacteria versus Phage: The Main Event" from January 10-12, 2024, focusing on the interactions between bacteria and phage, bringing together scientists inte

The Antimicrobial Chemotherapy Virtual Conference (6 & 7 February, 2024; free and online) is currently accepting submissions for poster presentations.

Canadian phage therapy biotech Cytophage Technologies and Cuspis Capital III Ltd. have announced a business combination agreement and concurrent financing. This means additional funds for Cytophage as it develops phage therapy for human and

Guy Mason and colleagues found that E. coli can persistently grow during phage predation in spatially confined environments.

Mikhail Skutel and colleagues demonstrate how the T5-like phage BF23 evades host-mediated DNA restriction and methylation.

Jumpei Fujiki and colleagues explore the fitness trade-offs between phage and antibiotic sensitivity in phage-resistant variants.

Mohammad Hashem Yousefi (KU Leuven) and colleagues have isolated and characterized a novel Salmonella Typhimurium phage called Arash, a novel species in the novel ‘Arashvirus’ genus, from hospital wastewater.

Kiran Bosco (Westmead Institute for Medical Research) and colleagues have reviewed the topic of therapeutic phage monitoring, proposed as an essential element of phage therapy protocols to generate data and fill knowledge gaps regarding the

Jean-Paul Pirnay and colleagues explore the question of whether magistral phage preparations could serve as a model for everyone.

Armata Pharmaceuticals will present positive topline data from the SWARM-P.a. clinical study at the North American Cystic Fibrosis Conference November 3rd in Phoenix, AZ, highlighting results of their novel inhaled multi-phage therapeutic f

Yi Wu and colleagues have discovered synergistic anti-phage activity of bacterial defence systems, shedding light on the compatibility and flexibility of these systems in response to specific environmental pressures.

G. Eric Bastien and colleagues have developed a machine learning model called Virus-Host Interaction Predictor (VHIP) to predict virus-host interactions and reconstruct complex virus-host networks in natural systems.

Karen Maxwell (University of Toronto) has been awarded the Arthur B. McDonald Fellowship for her research into antiviral defenses, which uncovered novel CRISPR inhibitors (anti-CRISPRs), according to a recent announcement by NSERC (Canada).

Andrea Fossati just announced that their grant for investigating phage-Mycobacterium tuberculosis interactions was funded by Vetenskapsradet (the Swedish Research Council).

Tagide deCarvalho and colleagues at the University of Maryland, Baltimore County have imaged a satellite phage attaching to another phage. Check out their paper, where they’ve described two novel satellite-helper phage systems, Mulch and Fl

The newest issue of Clinical Infectious Diseases features a special collection of articles exploring various aspects of phage therapy, including standardization of phage susceptibility testing, phage annotation and nomenclature, advanced ma